⌘K

Login Start Free

Home/Filings/4/0001214659-16-011135

4//SEC Filing

Anthera Pharmaceuticals Inc 4

Accession 0001214659-16-011135

CIK 0001316175operating

View on SEC.gov Company Profile

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 5:27 PM ET

Size

5.4 KB

Accession

0001214659-16-011135

Insider Transaction Report

Form 4

Period: 2016-04-27

Anthera Pharmaceuticals IncANTH

Director

Transactions

Award
Stock Option (right to buy)
2016-04-27+41,379→ 41,379 total
Exercise: $3.80Exp: 2026-04-27→ Common Stock (41,379 underlying)

Footnotes (1)

[F1]This non-statutory stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of April 27, 2016 and will be fully exercisable on April 27, 2017.

Documents

1 file

4
marketforms-35227.xmlPrimary
PRIMARY DOCUMENT

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001316175

Filing Metadata

Form type: 4
Filed: Apr 28, 8:00 PM ET
Accepted: Apr 29, 5:27 PM ET
Size: 5.4 KB

View on SEC.gov